198
Views
12
CrossRef citations to date
0
Altmetric
Clinical focus: Clinical Immunology & Infectious diseases - Original Research

Helicobacter pylori antibiotic resistance and correlation with cagA motifs and homB gene

ORCID Icon, , &
Pages 512-520 | Received 30 Nov 2019, Accepted 06 Apr 2020, Published online: 12 Apr 2020

References

  • Jonaitis L, Pellicano R, Kupcinskas L. Helicobacter pylori and nonmalignant upper gastrointestinal diseases. Helicobacter. 2018;23:e12522.
  • Kuna L, Jakab J, Smolic R, et al. Peptic ulcer disease: a brief review of conventional therapy and herbal treatment options. J Clin Med. 2019;8(2):179. .
  • Kavitt RT, Lipowska AM, Anyane-Yeboa A, et al. Diagnosis and treatment of peptic ulcer disease. Am J Med. 2019;132(4):447–456. .
  • Suzuki H, Mori H. World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat. J Gastroenterol. 2018;53:354–361.
  • Bachir M, Allem R, Benejat L, et al. Molecular detection of mutations involved in Helicobacter pylori antibiotic resistance in Algeria. J Antimicrob Chemother. 2018;73(8):2034–2038. .
  • Windham IH, Servetas SL, Whitmire JM, et al. Biofilm formation by Helicobacter pylori is differentially affected by common culture conditions and protein plays a central role in the biofilm matrix. Appl Environ Microbiol. 2018;AEM–00391.
  • Pellicano R, Zagari RM, Zhang S, et al. Pharmacological considerations and step-by-step proposal for the treatment of Helicobacter pylori infection in the year 2018. Minerva Gastroenterol Dietol. 2018;64(3):310–321. .
  • Yeo YH, Shiu S-I, Ho HJ, et al. First-line Helicobacter pylori eradication therapies in countries with high and low clarithromycin resistance: a systematic review and network meta-analysis. Gut. 2018;67(1):20–27. .
  • Ghotaslou R, Leylabadlo HE, Asl YM. Prevalence of antibiotic resistance in Helicobacter pylori: A recent literature review. World J Methodol. 2015;5(3):164.
  • Khademi F, Poursina F, Hosseini E, et al. Helicobacter pylori in Iran: A systematic review on the antibiotic resistance. Iran J Basic Med Sci. 2015;18:2.
  • Backert S, Blaser MJ. The role of CagA in the gastric biology of Helicobacter pylori. Cancer Res. 2016;76(14):4028–4031.
  • Oleastro M, Cordeiro R, Ferrand J, et al. Evaluation of the clinical significance of homB, a novel candidate marker of Helicobacter pylori strains associated with peptic ulcer disease. J Infect Dis. 2008;198(9):1379–1387. .
  • Markovska R, Boyanova L, Yordanov D, et al. Status of Helicobacter pylori cag pathogenicity island (cagPAI) integrity and significance of its individual genes. Infect Genet Evol. 2018;59:167–171.
  • Tegtmeyer N, Neddermann M, Asche CI, et al. Subversion of host kinases: a key network in cellular signaling hijacked by Helicobacter pylori CagA. Mol Microbiol. 2017;105(3):358–372. .
  • Yamaoka Y, El–Zimaity HM, Gutierrez O, et al. Relationship between the cagA 3ʹrepeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH. Gastroenterol. 1999;117(2):342–349. .
  • Wessler S, Backert S. A novel basolateral type IV secretion model for the CagA oncoprotein of Helicobacter pylori. Microb Cell. 2018;5(1):60.
  • Binh TT, Tuan VP, Dung HDQ, et al. Molecular epidemiology of Helicobacter pylori infection in a minor ethnic group of Vietnam: A multiethnic, population-based study. Int J Mol Sci. 2018;19(3):708. .
  • Suzuki M, Mimuro H, Suzuki T, et al. Interaction of CagA with Crk plays an important role in Helicobacter pylori–induced loss of gastric epithelial cell adhesion. J Exp Med. 2005;202(9):1235–1247. .
  • Mueller D, Tegtmeyer N, Brandt S, et al. c-Src and c-Abl kinases control hierarchic phosphorylation and function of the CagA effector protein in Western and East Asian Helicobacter pylori strains. J Clin Invest. 2012;122(4):1553–1566. .
  • Sicinschi L, Correa P, Peek R, et al. CagA C-terminal variations in Helicobacter pylori strains from Colombian patients with gastric precancerous lesions. Clin Microbiol Infect. 2010;16(4):369–378. .
  • Haddadi MH, Bazargani A, Khashei R, et al. Different distribution of Helicobacter pylori EPIYA-cagA motifs and dupA genes in the upper gastrointestinal diseases and correlation with clinical outcomes in iranian patients. Gastroenterol Hepatol Bed Bench. 2015;8:S37.
  • Morshedzadeh F, Abbasinia H, Zaeifi D. Prevalence and diversity of Cag (PAI) in Helicobacter pylori: study on gastric ulcer. J Gastrointest Digestive Syst. 2018;8(3):2.
  • Farzi N, Yadegar A, Aghdaei HA, et al. Genetic diversity and functional analysis of oipA gene in association with other virulence factors among Helicobacter pylori isolates from Iranian patients with different gastric diseases. Infect Genet Evol. 2018;60:26–34.
  • Servetas SL, Doster RS, Kim A, et al. ArsRS-dependent regulation of homB contributes to Helicobacter pylori biofilm formation. Front Microbiol. 2018;9;1497.
  • Hathroubi S, Servetas SL, Windham I, et al. Helicobacter pylori biofilm formation and its potential role in pathogenesis. Microbiol Mol Biol Rev. 2018;82(2):e00001–18. .
  • Belogolova E, Bauer B, Pompaiah M, et al. Helicobacter pylori outer membrane protein HopQ identified as a novel T4SS-associated virulence factor.. Cell Microbiol. 2013;15(11):1896–1912. .
  • Oleastro M, Ménard A. The role of Helicobacter pylori outer membrane proteins in adherence and pathogenesis. Biol. 2013;2(3):1110–1134.
  • Smith SI, Jolaiya T, Fowora M, et al. Comparison of polymerase chain reaction-based genotyping of Helicobacter pylori by direct polymerase chain reaction from biopsies and cultures from patients with dyspepsia in Nigeria. Minerva Biotecnol. 2019;31(4):116–121.
  • Suzuki H, Mori H. World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat. J Gastroenterol. 2018;53(3):354–361.
  • Lauener F, Imkamp F, Lehours P, et al. Genetic determinants and prediction of antibiotic resistance phenotypes in Helicobacter pylori. J Clin Med. 2019;8(1):53. .
  • Fakheri H, Firoozi MS, Bari Z. Eradication of Helicobacter pylori in Iran: a review. Middle East J Dig Dis. 2018;10(1):5.
  • Boyanova L, Mitov I. Geographic map and evolution of primary Helicobacter pylori resistance to antibacterial agents. Expert Rev Anti Infect Ther. 2010;8(1):59–70.
  • Farshad S, Alborzi A, Japoni A, et al. Antimicrobial susceptibility of Helicobacter pylori strains isolated from patients in Shiraz, Southern Iran. World J Gastroenterol. 2010;16(45):5746. .
  • Khademi F, Faghri J, Poursina F, et al. Resistance pattern of Helicobacter pylori strains to clarithromycin, metronidazole, and amoxicillin in Isfahan, Iran. J Res Med Sci. 2013;18:1056.
  • Pourakbari B, Mahmoudi S, Parhiz J, et al. High frequency of metronidazole and clarithromycin-resistant Helicobacter pylori in formalin-fixed, paraffin-embedded gastric biopsies. Br J Biomed Sci. 2018;75(2):61–65. .
  • Shokrzadeh L, Alebouyeh M, Mirzaei T, et al. Prevalence of multiple drug-resistant Helicobacter pylori strains among patients with different gastric disorders in Iran. Microb Drug Resist. 2015;21(1):105–110. .
  • Askarian M, Danaei M, Momeni M. A study of antibiotics self-medication at primary health care centers in Shiraz, Southern Iran. JHSSS. 2013;1(1):1–5.
  • Yonezawa H, Osaki T, Kamiya S. Biofilm formation by Helicobacter pylori and its involvement for antibiotic resistance. Biomed Res Int. 2015;2015:1–9.
  • Wong EHJ, Ng CG, Chua EG, et al. Comparative genomics revealed multiple Helicobacter pylori genes associated with biofilm formation in vitro. PloS One. 2016;11(11):e0166835. .
  • Eslami G, Taheri S, Baseri N, et al. Prevalence of Helicobacter pylori and determination of antibiotic resistance in patients with gastritis referred to Shahid Beheshti University of Medical Sciences Hospitals in Tehran Between 2010 and 2011. Arch Clin Infect Dis. 2012;8(1):18–22.
  • Karabiber H, Selimoglu MA, Otlu B, et al. Virulence factors and antibiotic resistance in children with Helicobacter pylori gastritis. J Pediatr Gastroenterol Nutr. 2014;58(5):608–612. .
  • Argent RH, Zhang Y, Atherton JC. Simple method for determination of the number of Helicobacter pylori CagA variable-region EPIYA tyrosine phosphorylation motifs by PCR. Clin Microbiol. 2005;43(2):791–795.
  • Panayotopoulou EG, Sgouras DN, Papadakos K, et al. Strategy to characterize the number and type of repeating EPIYA phosphorylation motifs in the carboxyl terminus of CagA protein in Helicobacter pylori clinical isolates. Clin Microbiol. 2007;45(2):488–495. .
  • Boyanova L, Markovska R, Yordanov D, et al. Clarithromycin resistance mutations in Helicobacter pylori in association with virulence factors and antibiotic susceptibility of the strains. Microb Drug Resist. 2016;22(3):227–232. .
  • Khan A, Farooqui A, Manzoor H, et al. Antibiotic resistance and cagA gene correlation: a looming crisis of Helicobacter pylori. World J Gastroenterol. 2012;18(18):2245. .
  • Abadi ATB, Rafiei A, Ajami A, et al. Helicobacter pylori homB, but not cagA, is associated with gastric cancer in Iran. J Clin Microbiol. 2011;49(9):3191–3197.
  • Hussein NR. A study of Helicobacter pylori outer-membrane proteins (hom) A and B in Iraq and Turkey. J Infect Public Health. 2011;4(3):135–139.
  • Dabiri H, Jafari F, Baghaei K, et al. Prevalence of Helicobacter pylori vacA, cagA, cagE, oipA, iceA, babA2 and babB genotypes in Iranian dyspeptic patients. Microb Pathog 2017;105:226–230.
  • Kargar M, Ghorbani-Dalini S, Doosti A, Najafi A. Five-year monitoring of considerable changes in tyrosine phosphorylation motifs of the Helicobacter pylori cagA gene in Iran. J Appl Genet 2014;55:417–422.
  • Schmidt HMA, Goh KL, Fock KM, et al. Distinct cagA EPIYA motifs are associated with ethnic diversity in Malaysia and Singapore. Helicobacter 2009;14:256–263.
  • Jung SW, Sugimoto M, Graham DY, Yamaoka Y. homB status of Helicobacter pylori as a novel marker to distinguish gastric cancer from duodenal ulcer. J Clin Microbiol 2009;47:3241–3245.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.